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Abstract 
Alcohol Use in Individuals with HIV: An Evaluation of Neurocognitive Performance 
Kara R. Newman, M.S. 
Mary V. Spiers, Ph.D. 
 
 Existing neuropsychological research involving HIV+ individuals has not 
systematically considered the influence of alcohol use and depression on cognitive 
performance, though both commonly co-occur with HIV. Moreover, few studies have 
examined the relationship between subjective cognitive concerns and objective task score 
in HIV. Evidence suggests that these measures may be discordant in HIV populations. 
We administered a computerized cognitive battery (the CogState Battery and the Iowa 
Gambling Task) to 122 HIV+ men and women who reported consuming alcohol in the 
past 90 days, to characterize neuropsychological performance in executive functioning 
(EF), verbal learning/memory, visual learning/memory, attention, working memory, 
psychomotor speed, and decision-making. Participants also completed self-report 
measures assessing recent alcohol consumption, perceived cognitive impairment, and 
depressive symptoms. We hypothesized that higher levels of recent drinking would be 
associated with poorer cognitive test scores, particularly in the domains of EF and 
memory. We found a significant influence of heavy alcohol use on objective cognitive 
performance in immediate verbal memory, but not delayed verbal memory or EF. Higher 
levels of drinking were related to more self-reported cognitive complaints in memory, 
EF, and impulsivity. Depressive symptoms, although limited in our sample, were 
correlated with heavier drinking and poorer self-appraisal of cognition. Depression score 
was not correlated with objective task performance in any domain. This research provides 
an initial step towards defining the neuropsychological profile of HIV+ drinkers.
 
1 
1. Introduction 
1.1 Study Objectives  
Even in the era of highly-active antiretroviral therapy (HAART
1
), mild to moderate 
cognitive deficits persist for many HIV+ men and women, with wide variability observed 
between individuals (Woods et al., 2009). As noted by Reger and colleagues (2002; p. 
417): “The significant heterogeneity of functioning observed [in HIV]…may be a result 
of factors such as depression, substance use, head injury, age, IQ, and educational 
differences between groups.”  This study examined the associations of several of these 
key factors (i.e., alcohol use, depressive symptoms, premorbid intellectual functioning, 
years of education) with cognitive performance and self-appraisal of cognitive 
functioning in a sample of HIV+ men and women who drink alcohol.  
HIV+ drinkers may face unique clinical complications. Heavy drinking is common 
among HIV-infected persons (Samet et al., 2004) and represents a serious public health 
threat, as there is a higher incidence of HIV infections among repeated binge drinkers 
(Shuper et al., 2010). For the seropositive individual, chronic alcohol use can cause 
declines in learning, memory, and visuospatial ability (Fama et al., 2012; Oscar-Berman, 
1990). Alcohol use in HIV is also associated with depression, which introduces an 
additional potential mechanism of cognitive impairment (Sassoon et al., 2012). 
Ultimately, awareness of the psychiatric and neuropsychological complications 
                                                     
1
 HAART refers to a combination treatment regimen of one or more antiretroviral (ARV) drugs, which are 
medications that slow or block the replication of the human immunodeficiency virus, thereby decreasing 
the viral load in the body. Major classes of ARV drugs include nucleotide analogue reverse transcriptase 
inhibitors, non-nucleoside reverse transcriptase inhibitors, and protease inhibitors, which act to disrupt 
replication at different stages of the HIV cycle. Though the term HAART has been used interchangeably 
with “cART” and “ART,” ART can also refer to a holistic treatment approach that involves removing 
barriers to medication compliance, ensuring proper nutrition, providing psychosocial support, etc. (Cysique 
et al., 2006; Sacktor et al., 2002). 
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experienced by HIV+ drinkers is a key consideration in improving treatment for these 
individuals.  
The primary aim of this study was to explore the demographic, psychiatric, and 
cognitive correlates of co-occurring HIV and alcohol use, as measured by subjective self-
report and objectively-measured performance on neuropsychological testing. In the 
following literature review, the general neuropsychological profiles of HIV and alcohol 
use are reviewed, with a focus on shared cognitive weaknesses. The role of depression is 
briefly considered with regard to neurocognitive performance, drinking, and subjective 
cognitive complaints in HIV. Lastly, the clinical challenges of diagnosing and treating 
HIV-associated neurocognitive impairment (HAND; See Table 1) are discussed. 
 
1.2 HIV Infection and Mechanisms of CNS Pathology 
 The Centers for Disease Control (CDC) estimate that 1.2 million people in the 
United States are living with HIV infection and that approximately 50,000 Americans 
become newly infected each year (Prejean et al., 2011). In many patients, HIV can cause 
cognitive deficits. Damage to the central nervous system can occur in several ways 
(Foley et al., 2008). After the acute period of HIV infection, which lasts about 4 weeks, 
viral replication and subsequent immune destruction occurs with a variable time course, 
depending on the individual (Ellis et al., 2009). Once the virus has crossed the blood-
brain barrier, toxic viral proteins (Tat and gp120) and the effects of glutamate 
excitotoxicity cause widespread synapto-dendritic injury. The result is indiscriminate 
destruction of brain cells – neurons, astrocytes, and microglia alike. In response, an up-
regulation of repair and regeneration mechanisms is triggered in the brain, which includes 
3 
 
a sharp increase in chemical mediators of inflammation and immunity (i.e., cytokines, 
chemokines). Unfortunately, these “host factors” may cause further cognitive 
compromise through damaging effects of neural inflammation (Perdidsky et al., 2011). 
Resolution of some viral and host factors is possible with antiretroviral treatment, and 
may lead to partial neurocognitive improvement (Ellis et al., 2011).   
 Ultimately, the neuropathology of HIV exerts effects across broad neural 
networks. The neurotoxic damage is more pronounced in sub-cortical brain regions, 
similar to the pattern seen in Parkinson’s disease and multiple sclerosis (Woods et al., 
2009). In particular, HIV-associated cell loss most commonly affects the striatum and 
white matter connections between the striatum and prefrontal cortex (PFC). Striato-
frontal white matter loss has been correlated with neurocognitive performance, including 
executive dysfunction and slowed psychomotor processing speed (Moore et al., 2006). 
Common patterns of neurocognitive weaknesses observed in HIV are outlined below.  
 
1.3 The Cognitive Profile of HIV 
1.3.1 The Frontal Lobes and Executive Functioning in HIV 
As defined by Damasio and Anderson (2003), executive functioning (EF) is a 
necessary cognitive component of our “global adaptive capacity” as human beings.  The 
construct of EF includes higher-order functions such as planning, problem-solving, 
working memory, attentional allocation, inhibition, and self-monitoring (Zillmer, Spiers, 
& Culbertson, 2008). Together, these abilities orchestrate goal-directed behavior. EF 
performance can be the product of several interrelated processes, all of which can be 
subject to “executive control.” For example, EF plays a role in psychomotor performance 
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on speeded tasks, the use of search and retrieval strategies on memory recall tasks, ability 
to plan, abstract reasoning, and decision-making patterns (Sarazin et al., 1998). 
 Performance in the domain of EF is closely associated with the integrity of the 
frontal lobe (Damasio & Anderson, 2003). The frontal lobes are interconnected with 
almost all other brain regions, and serve to mediate complex cognitive, emotional, and 
social aspects of human consciousness. The dorsolateral prefrontal cortex (DLPFC) and 
orbitofrontal cortex (OFC) of the frontal lobe have been particularly well-studied in 
relation to behavior and cognition. Components of cognition attributed to the DLPFC 
include attention, working memory, cognitive flexibility (“set-shifting”), verbal fluency, 
planning, organization, memory search and retrieval strategies, and judgment (Zillmer, 
Spiers, & Culbertson, 2008). In contrast, the OFC is associated with affective and 
motivational aspects of behavior such as impulsivity, sensation seeking, behavior 
modification in response to risk/reward/punishment, and emotional modulation (Berlin, 
Rolls, & Kischka, 2004; Sarazin et al., 1998). Functional neuroimaging studies have 
demonstrated that the OFC and DLPFC send and receive connections with the striatum 
and hippocampus (Damasio & Anderson, 2003). These sub-cortical pathways are 
especially susceptible to HIV-related destruction, and published neuropsychological 
findings from seropositive individuals appear consistent with damage to these regions 
(Woods et al., 2009).  
 Deficits in EF have been described as the most central aspect of HIV-related 
cognitive impairment (Cattie et al., 2012; Joska et al., 2011). Longitudinally, EF shows 
significant decline from the early to late stages of HIV disease (Reger et al., 2002). In 
cross-sectional studies utilizing healthy comparison groups, individuals with HIV exhibit 
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weaker performance on tasks of problem-solving and cognitive flexibility (i.e., 
Wisconsin Card Sorting Test, Trails B, Category Test), planning (i.e., Tower tasks), 
inhibition (i.e., Stroop color-word interference) and decision-making (i.e., Iowa 
Gambling Task) (Grant, 2008; Martin et al., 2004; Thames et al., 2012; Woods et al., 
2009).  
 Decision-making performance on the Iowa Gambling Task (IGT) is regarded as 
uniquely valuable in identifying differences between healthy control populations and both 
HIV and substance-using populations, and was therefore selected for inclusion in the 
present study, in addition to the CogState computerized battery described below. 
Impulsive decision making plays an important role in the neuropathology of addiction 
(Volkow & Fowler, 2000) as well as in the risky behaviors associated with increased 
likelihood of HIV transmission (Samet et al., 2004). Clearly, this area warrants further 
study in the context of comorbid HIV and alcohol use.  
 According to Bechara et al. (2000), decision-making refers to complex cognitive 
and affective processes involved in the “ability to select the most advantageous response 
from an array of possible behavioral choices.” Task performance on the IGT assesses this 
ability via a simulated gambling task in which the goal is to earn as much money as 
possible by choosing from an array of “good” versus “bad” decks of cards. Research 
demonstrates that the IGT offers a valuable indicator of real-world behavioral problems 
(i.e., impulsivity, risk-taking), even among individuals with intact memory and 
intellectual functioning (Reger et al., 2002; Martin et al., 2004). Recent findings obtained 
from HIV patients have consistently demonstrated weaknesses in decision-making 
performance on the IGT compared to healthy controls (Gonzalez et al., 2010, Martin et 
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al., 2004, Thames et al., 2012). In spite of the real-world generalizability of the IGT, the 
specific cognitive deficits underlying poor task performance are not well understood, and 
require additional study (Buelow & Suhr, 2009).  
1.3.2 Learning & Memory in HIV 
 A comprehensive literature review by Woods et al. (2009) outlines a pattern of 
mild-to-moderate learning and memory impairment in HIV, for both visual and verbal 
modalities. As with executive functioning, explicit learning and memory deficits appear 
to worsen with disease progression. In general, learning processes are less efficient in 
individuals with HAND, although long-term retention of learned material is typically 
intact (Peavy et al., 1994). Consistent with sub-cortical dysfunction, this mixed encoding 
and retrieval profile is characterized by initial learning that is retained over time, with 
optimal performance observed when delayed memory is tested via recognition (Grant, 
2008; Reger et al., 2002, Woods et al., 2009). Stated another way, delayed free recall 
performance may be lower in HIV+ individuals, even among those with intact encoding 
and consolidation abilities. This deficit in free recall has been attributed primarily to 
executive dysfunction – specifically, impairment in mechanisms of executive search and 
retrieval strategies mediated by the DLPFC (e.g., failure to use semantic clustering on 
list-learning tasks; Grant, 2008; Woods et al., 2009). On neuropsychological testing, part 
of the variance in immediate memory recall performance may be accounted for by 
executive ability.  
 Prospective memory (ProM), defined as the ability to remember to execute a 
future intention, is similarly impaired in HAND (Carey et al., 2006), although this 
construct was not assessed in the present study. ProM is also heavily dependent on frontal 
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systems, and ProM performance demonstrates correlations with both EF and verbal 
working memory. Taken together, this neurocognitive profile of deficits in learning, 
delayed free recall, and ProM impairments observed in HIV appears consistent with 
disruptions to prefrontal circuitry.  
1.3.3 Processing Speed and Psychomotor Functioning in HIV 
 Loss of white matter exerts detrimental effects on speed of information processing 
(bradyphrenia) and psychomotor functioning (bradykinesia) in HIV. As white matter 
volume loss increases with advanced disease, deficits in these functions may become 
more pronounced. Basic motor slowing and disturbances in coordination are commonly 
observed even in mild cases of HAND, consistent with changes in striatal and prefrontal 
circuitry (Grant, 2008). Notably, a general pattern of cognitive slowing is evident on 
tasks with and without a motor component (e.g., Trails A and Stroop; Woods et al., 
2009). Martin et al. (1999) suggest that both motor and cognitive processing speed 
deficits can be exacerbated in HIV as task demands increase, which may have 
implications for activities of daily living (e.g., managing finances or a complex 
medication regimen). In the most advanced cases of HIV-associated motor dysfunction, 
severe disorders of movement such as chorea, dyskinesia, and dystonia can occur (Woods 
et al., 2009). 
1.3.4 Attention and Working Memory in HIV 
 
Given the link between higher order attentional processes and executive 
functioning, some aspects of attention and working memory may be affected by HIV-
associated prefrontal dysfunction. According to Mirsky’s model of attention, the 
executive (or anterior) attention system is responsible for determining how attention is 
8 
 
allocated during a task. This system encompasses the processes of attention shifting, 
inhibitory control, and error detection (Zillmer, Spiers, & Culbertson, 2008). Likewise, in 
Baddeley’s theoretical model of working memory, a “central executive” is responsible for 
controlling attention. This executive monitoring process regulates the mental 
manipulation of information that is held “on-line” in the temporary store of working 
memory. Therefore, deficits in the operation of these executive controls can manifest as 
poor performance on more complex tasks of attention and working memory in spite of 
normal underlying abilities in the domain of attention. In seropositive patients, basic 
attention and concentration abilities are relatively spared, remaining intact until later 
stages of the disease (Woods et al., 2009) – although further research is needed to clarify 
the exact neurodegenerative mechanism of HAND on attention and working memory.  
 
1.4. Other Clinical Concerns in HIV 
1.4.1 Identification and Clinical Diagnosis of Cognitive Problems in HIV 
 HAND is a term that encompasses three subtypes of cognitive disorders 
diagnosed among individuals living with HIV/AIDS (Antinori et al., 2007; Woods et al., 
2009). In order of increasing severity, they are: asymptomatic neurocognitive impairment 
(ANI), HIV-associated mild neurocognitive disorder (MND), and HIV-associated 
dementia or HAD (See Table 1; adapted from Gisslen et al., 2011).  A diagnosis of HAD 
is sometimes interchanged with the term formerly used to identify this condition, AIDS 
dementia complex (ADC).  
 According to Robertson et al. (2007), the majority of HAND cases are diagnosed 
as ANI, reflecting no functional impairment. An estimated 20-40% of HAND cases are 
9 
 
classified as MND (Grant et al., 2005). Fortunately, the percentage of patients with HAD 
has steadily declined in recent years with the advent of HAART. Moreover, two studies 
have demonstrated that individuals with HAND can improve neurocognitively over time 
with treatment, suggesting at least partial reversal of deficits with an effective HAART 
regimen (MacArthur, 2004; Robertson et al., 2007) 
1.4.2 Pre- and Post-HAART Cognitive Trends 
 Regardless of diagnostic subtype, individuals with HAND can experience 
cognitive impairment in multiple domains, including executive function, learning, 
retrospective and prospective memory, motor coordination, processing speed, sustained 
attention, and working memory (Grant et al., 1995; Hinkin et al., 2002b; Liner et al., 
2010). Cysique et al. (2006) conducted a meta-analysis to determine the distinct cognitive 
profiles associated with HIV and AIDS for patients in the pre-HAART era. Results 
suggested that the transition from HIV to AIDS was associated with progressive decline 
in the domains of attention, psychomotor speed/motor coordination, and learning, all of 
which progressed in severity from mild to moderate (Cysique et al., 2006). Individuals 
with AIDS demonstrated additional deficits in verbal memory and executive function. 
Individuals carrying a diagnosis of ADC were the most cognitively compromised, 
demonstrating global and severe cognitive impairments in all of the above domains.  
 It is noteworthy that HAD and ADC were much more commonly observed in the 
era before HAART, and tended to correlate with markers of advanced disease, such as 
low CD4 cell count and high viral load (Gisslen et al., 2011; Robinson-Papp et al., 2009). 
Yet in spite of the declining incidence of HAD in the current era, the prevalence of 
milder forms of HAND (ANI and MND) has persisted today, even among individuals 
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who are not immunosuppressed (Grant et al., 2005; McArthur, 2004). There is also 
significant heterogeneity observed among seropositive individuals receiving HAART, 
which may be due in part to other influences on cognition (e.g., co-occurring depression, 
substance abuse, premorbid IQ). The influence of these factors in HAND requires further 
investigation. 
1.4.3 Immune System Integrity and Cognitive Rebound 
 Converging evidence links immunosuppression in HIV with neuropsychological 
impairment. Individuals with a history of significant immunosuppression (e.g., CD4 
count <200) are more likely to experience sustained cognitive symptoms, suggesting that 
there is a non-reversible component of HIV-related neurological damage (Robertson et 
al., 2007). In a prospective cohort study of 1,160 individuals undergoing HAART trials, 
Robertson and colleagues (2007) found a correlation between current immune status and 
degree of cognitive impairment, indicating that CD4 count may be indicative of overall 
neurocognitive integrity. Similarly, a review by Al-Khindi et al. (2011) concluded that 
cognitive improvement in executive function, attention, and motor function was 
correlated with the change in CD4 cell count (i.e., the extent of immune system 
restoration) following HAART initiation. In further support of these findings, Ellis and 
colleagues (2011) reported that higher CD4 nadir (an indicator of preserved immunity) at 
the initiation of HAART was associated with a reduced risk of HAND. Though the exact 
relationship between HIV progression and neurological dysfunction is not fully 
understood, these studies suggest that HAART limits or partially reverses cognitive 
decline in some HIV+ individuals. Treatment may be most valuable in the early stages of 
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the disease as a preventative strategy against immunosuppression and the initial onset of 
neurocognitive impairment. 
 A successful response to HAART is associated with improvements in EF. This 
executive rebound corresponds to increases in CD4 count (Cohen et al., 2001; Joska et 
al., 2010; Robinson-Papp et al., 2009). A literature review by Joska et al. (2010) of 15 
neuropsychological studies of HIV patients determined that effective HAART led to 
partial but not complete reversal of cognitive deficits. A more recent meta-analysis found 
that HAART was associated with modest improvements in attention, executive function, 
and motor function, but did not significantly improve verbal memory or visual memory 
(Al-Khindi et al., (2011). Functions mediated by the frontal lobe may be more sensitive 
to HAART and thus more likely to improve than functions mediated by other brain 
regions. 
 Even in some HAART-treated individuals with acceptable CD4 counts and 
undetectable viral load levels, HAND can be a significant problem (Grant et al., 2005; 
Robinson-Papp et al., 2009). The increasingly heterogeneous population of seropositive 
individuals presents an ongoing challenge in identifying the neuropsychological profile of 
HIV infection, due to variation in the nature and severity of neuropsychological decline. 
Other neuropsychiatric and socioeconomic factors can influence cognitive performance. 
For example, lower educational attainment among HIV-infected individuals at HAART 
initiation has been found to predict persistent neuropsychological deficits, independent of 
long-term HAART efficacy and CD4 count (Tozzi et al., 2007). Further exploration of 
contributors to cognitive impairment in HAART-treated HIV patients is clearly needed, 
and is provided in the present study. 
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1.5 Identifying Functional Impairment in HIV 
1.5.1 Utility of Neuropsychological Testing 
As shown in Table 1, formal diagnosis of HIV-associated neurocognitive 
impairment (HAND) is partially determined by the magnitude of problems in everyday 
functioning (Blackstone et al., 2012; Gorman et al., 2009; Heaton et al., 2004; Hinkin et 
al., 2002a; Liner et al., 2010), and is typically assessed via neuropsychological testing 
and patient self-report.  Executive function and prospective memory deficits may be most 
detrimental to everyday functioning abilities (Liner et al., 2010; Woods et al., 2009).  
HIV-associated cognitive deficits in EF, memory, attention, and motor coordination have 
been shown to significantly predict several aspects of everyday functioning, including 
driving, medication adherence, and financial management (Liner et al., 2010; Thames et 
al., 2011). For example, performance on a task of visual attention was linked to driving 
ability and number of accidents in the past year (Heaton et al., 2004). Deficits in 
executive functioning, attention, and memory have been also shown to be associated with 
unemployment (Heaton et al., 2004), and only a relatively small percentage of HIV+ 
individuals are able to maintain employment or find employment after losing a job (Liner 
et al., 2010).  
 Recently, Cattie et al. (2012) evaluated the executive construct of planning 
(operationalized as performance on the Tower of London-DX (TOL-DX) task) in 53 
individuals with HAND, 109 HIV-infected persons without HAND, and 82 seronegative 
participants. The authors found that the HAND group performed significantly more 
poorly than HIV-infected individuals without HAND on virtually every element of the 
TOL-DX task, including number of correct moves, total moves needed to solve each 
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problem, execution time, time violations, and rule violations. Elevated total moves and 
rule violations were significant independent predictors of self-reported decline in 
everyday functioning and unemployment status in HAND patients. In addition to 
neuropsychological performance, self-reported measures of functional impairment must 
be considered in HIV. Their strengths and limitations are described in the next section. 
1.5.2 Utility of Self-Report Measures 
 Assessing cognitive problems and functional impairment via self-report may 
provide important information that neuropsychological testing does not capture. 
However, relying on self-appraisal of cognitive functioning is problematic, primarily 
because cognitive dysfunction can cause poor insight and judgment, as well as an under-
appreciation of cognitive deficits (Thames et al., 2011).  Second, there is a lack of 
available self-report measures that are specific to HAND. As outlined by Heaton et al. 
(2004) “…most available instruments, such as self-report questionnaires…or even more 
direct and objective measures of functional ability…are designed for elderly subjects 
with dementing disorders (e.g., Alzheimer’s dementia). Although useful in these 
populations, such instruments have proven insensitive to the mild [neuropsychological] 
impairments observed in the generally younger HIV-infected adult population,” (Heaton 
et al., 2004).  
Heaton and the HIV Neurobehavioral Research Program at the University of 
California – San Diego have adapted the Person’s Assessment of Own Functioning 
Inventory (PAOFI) to create a targeted measure of cognitive self-appraisal for HIV (Au 
et al., 2008; Richardson-Vejlgaard et al., 2009). This assessment addresses cognitive 
concerns in the domains of memory and higher order cognitive functions. Patients are 
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asked to rate the frequency with which they experience specific cognitive complaints on a 
Likert scale from 1 (Almost Always) to 6 (Almost Never). Notably, at least one study 
showed that PAOFI score did not correlate with performance-based neuropsychological 
data, though that sample was comprised of non-HIV-infected substance users 
(Richardson-Vejlgaard et al., 2009).  
 Blackstone and colleagues (2011) examined whether self-report measures of 
everyday functioning characterized HAND as effectively as their analogous performance-
based measures. The researchers assessed 674 HIV-infected participants (233 of whom 
met criteria for a HAND diagnosis) with a comprehensive neurocognitive battery and 
measured functional decline via self-report and performance-based measures. HAND 
diagnoses were then assigned using three approaches (1) self-report measures only, (2) 
performance-based measures only, and (3) combined self-report and performance-based 
measures. Interestingly, objective performance predicted functional disability, whereas 
subjective self-rating of functional disability was associated with depression (Blackstone 
et al., 2012). Participants classified as functionally impaired based on performance alone 
were more likely to be unemployed and more immunosuppressed, whereas those 
classified as functionally impaired based on self-report alone exhibited more depressive 
symptoms (Blackstone et al., 2012). Thus, self-report measures of cognitive functioning 
may be affected by the presence of depressive symptoms. Depression may in fact play a 
causal role in lowering self-appraisal of cognitive functioning. Blackstone et al. (2012) 
concluded that the value of self-report measures is not in corroborating 
neuropsychological data, but rather in capturing unique variance related to depression and 
psychiatric distress that would not otherwise be detected in a typical cognitive battery. 
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1.5.3 Impact of Depression  
 Among seropositive patients, depression impacts life functioning, 
neuropsychological performance on EF and decision-making tasks (Thames et al., 2012), 
and self-report measures of perceived cognitive problems (Blackstone et al., 2011; 
Sassoon et al., 2012). The findings of Blackstone and colleagues regarding subjective 
cognitive impairment are noteworthy, as they suggest that depressed individuals are more 
likely to rate themselves as impaired, even when they perform within normal limits on 
testing. In clinical settings where neurocognitive testing is not conducted, it would be 
possible for such patients to be misdiagnosed with HAND, especially if mood-related 
problems are not being acknowledged and treated. Given the level of depressive 
symptoms in the HIV population, relying solely on self-report measures could 
overestimate the prevalence of HAND and/or the severity of its associated functional 
impact (Gisslen et al., 2011).  
 Among HIV+ men and women with clinical depression, increased incidence of 
depressive symptoms is also associated with higher levels of alcohol use (Sullivan et al., 
2008). Drinking introduces a third level of risk for cognitive impairment, in addition to 
the potential impact of depression and viral factors. The impact of alcohol on cognitive 
functioning is reviewed in the next session, and the implications for HIV+ drinkers are 
discussed. 
  
1.6 Recent Alcohol Use and Cognitive Impairment 
 Alcohol Use Disorders (AUDs) and alcohol-related impairments are among the 
most widespread psychiatric disorders in the world (WHO, 2002). Excessive use of 
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alcohol plays a substantial causal role in a number of serious adverse health outcomes, 
with an estimated 3.8% of worldwide deaths in 2004 attributable to alcohol (Rehm et al., 
2009). The nature and magnitude of cognitive problems associated with AUDs appear to 
vary based on several demographic factors, including gender, age, health, and family 
history, and may also be influenced by quantity and chronicity of alcohol use (Oscar-
Berman et al., 2007). Although the long-term cognitive consequences of chronic heavy 
drinking continue to be evaluated in neuropsychological research, common themes have 
been convincingly demonstrated by previous research. Perhaps the most well-known 
cognitive disorder associated with chronic alcohol use is the severe memory disorder 
known as Korsakoff’s syndrome. Yet even in the absence of severe structural damage to 
the brain, mild to moderate cognitive deficits can occur with chronic alcohol use  
 Chronic heavy drinking is associated with several hallmark deficits. As with HIV, 
executive dysfunction is often observed in among individuals with an alcohol use 
disorder (AUD). In one study of executive function in AUD, Ratti et al. (2002) compared 
22 men diagnosed with current alcohol dependence and 22 non-drinking controls on a 
range of well-known neuropsychological tasks of EF. The AUD group showed 
statistically significant impairment relative to controls on all but one of the tasks (Ratti et 
al., 2002). Although the report did not include a measure of effect size, the observed 
magnitude of differences was large on certain tasks (e.g., an 80-second difference 
between groups on average time to completion of Trails B), supporting the association 
between drinking variables and clinically meaningful differences in EF. 
 Alcohol-related executive dysfunction has since been demonstrated by a number 
of subsequent studies (Bjork et al., 2004; Fein et al., 2004; Fernandez-Serrano et al., 
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2011; Goldstein et al., 2004). In the realm of decision-making and impulsivity, Fein et al. 
(2004) found that the number of disadvantageous decisions made on the IGT was 
correlated with duration of peak lifetime alcohol use in a sample of patients in long-term 
remission from alcohol dependence. Bjork et al. (2004) also evaluated abstinent alcohol-
dependent patients’ (average length of abstinence = about 7 years) performance on a 
simulated gambling task, measuring impulsivity and delay discounting. They found that, 
compared with controls, abstinent alcoholics showed greater rates of commission errors 
and risky responses on the risk-taking paradigm, more severe devaluation of delayed 
reward, and higher impulsivity scores.  
 Studies show that alcohol use adversely impacts visuospatial abilities 
(Richardson-Vejlgaard et al., 2009; Fama et al., 2012), as well as both retrospective and 
prospective memory processes (Heffernan, 2008; Schottenbauer et al., 2007). These 
patterns have also been demonstrated in AUD populations even months after sobriety is 
attained, indicating that they are not readily reversible, nor are they simply the product of 
acute intoxication (Fernandez-Serrano et al., 2011). This profile of alcohol-related 
cognitive impairment is consistent with the significant fronto-cerebellar damage caused 
by alcohol neurotoxicity (Sullivan et al., 2003). Given the broad neurological circuitry 
involved, it is not surprising that working memory abilities and psychomotor speed are 
frequently significantly impaired as well, especially at heavier levels of drinking 
(Fernandez-Serrano et al., 2011; Ratti et al., 2002).  
 Fernandez-Serrano and colleagues (2011) conducted a comprehensive review of 
the extant literature on the short-term and long-term neuropsychological correlates of 
various drugs of abuse. The authors examined neuropsychological outcomes for 
18 
 
individuals with “pure” alcohol abuse or dependence, as well as for individuals with 
heavy alcohol use and comorbid drug use. In the realm of drinking, their findings 
supported significant alcohol-related deficits in EF (i.e., mental flexibility/set-shifting and 
impulsivity), most of which persisted during early abstinence from alcohol (1-6 months). 
Significantly, no deficits were evident at long-term abstinence (>6 months), regardless of 
alcohol use chronicity. These findings corroborate a smaller-scale study by Beatty et al. 
(2000), in which it was reported that the degree of neuropsychological impairment in 162 
alcohol dependent subjects was correlated with the quantity of alcohol consumption in 
the past 6 months, but showed no relationship with chronicity. Simply stated, the number 
of years for which subjects drank alcohol was less predictive of cognitive problems than 
the amount of recent drinking. This finding is relevant to the present study, in which we 
consider drinking behavior over the 90 days prior to the study visit. Overall, studies 
suggest that quantity of recent alcohol use is associated with cognitive deficits, though it 
is yet to be determined whether these findings may also hold true among seropositive 
drinking populations. 
 
1.7 Cognition in HIV+ Drinkers 
 As described above, HIV and alcohol use appear to be associated with cognitive 
decline, particularly in the domain of EF. Both conditions can adversely affect frontal 
circuits in the brain (Foley et al., 2008). Perdidsky et al. (2011) reviewed 
neurodegenerative factors that may be comparable in HIV and alcohol use, and 
concluded that inflammatory processes are likely to mediate neurological damage in both 
conditions: “…causes of HIV-1-associated neurotoxicity are comparable to those 
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mediating alcohol-induced neuronal injury… [Causes include] oxidative stress, 
overproduction of pro-inflammatory factors, impairment of the blood-brain barrier, and 
glutamate-associated neurotoxicity” (Persidsky et al., 2011; p. S63).  
 In the existing neuropsychological literature comparing HIV+ drinkers to HIV+ 
non-drinkers and HIV-negative drinkers, most studies considered performance in only 
one cognitive domain (rather than examining patterns in a comprehensive battery). 
Nonetheless, findings suggest that individuals with comorbid HIV and alcohol use 
disorders show greater deficits in EF, verbal and visuospatial learning and memory, 
motor coordination, and  psychomotor speed than individuals with HIV infection or AUD 
alone (Fama et al., 2012; Fama et al.; 2011; Fama et al., 2009; Green et al., 2004; 
Rothlind et al., 2005; Sassoon et al., 2007). Although formal AUD diagnosis was not 
assigned in the present study, it was expected that heavy drinkers would exhibit lower 
performance than light drinkers, particularly in the domains of EF and memory.  
 Foley et al. (2008) reviewed studies examining the effects of illicit substances on 
neuropsychological function in HIV+ individuals. Although none of these studies focused 
solely on alcohol, the outcomes almost unanimously supported the idea that neurotoxic 
substances interact with HIV to produce greater cognitive deficits than HIV alone or use 
of the substance alone. In one noteworthy study of the Iowa Gambling Task, Martin et al. 
(2004) found that stimulant use was associated with greater deficits in decision-making in 
HIV+ substance dependent individuals than in HIV-negative substance dependent 
individuals. In summary, both heavy drinking and HIV are associated with executive 
impairment, which may reflect dysfunction of the prefrontal cortex. As Shuper et al. 
(2010) discuss in their review of alcohol use in the context of HIV, it is possible that 
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alcohol-induced deficits in EF and decision making could in fact underlie the increased 
risk of acquiring HIV that is observed among problem drinkers. This hypothesis requires 
further longitudinal study. 
 
1.8 Summary & Statement of the Problem 
 Cognitive impairment is a serious concern for HIV-infected individuals, which 
can potentially interfere with everyday functioning. Although heavy alcohol use, 
depressive symptoms, and EF impairments appear to be particularly prevalent and 
debilitating factors in HIV, these constructs have not been explored in relation to 
performance on a comprehensive neuropsychological test battery. The overall 
neurological profile of HIV reflects a sub-cortical neurodegenerative process that can 
cause difficulties with EF, memory, and decision-making, as well as motor coordination, 
speed, and attention, especially at more advanced stages of the disease. Fortunately, rates 
of HIV-associated dementia have declined with the introduction of HAART and 
prevention of severe immunosuppression (Cysique et al., 2006).  
 Heavy drinking is associated with a range of cognitive problems, including 
executive dysfunction, weakness in memory and learning, impaired psychomotor 
coordination and speed, visuospatial deficits, and impulsive decision-making. 
Preliminary evidence suggests that HIV+ drinkers with AUD may fare worse on 
neuropsychological testing than HIV+ non-drinkers.  However, more research is needed 
to clarify the neuropsychiatric factors that contribute to objective weaknesses and 
subjective cognitive concerns in HIV+ individuals who drink alcohol.  
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 The assessment and diagnosis of HIV-associated neurocognitive disorders 
(HAND) represents a clinical challenge, as performance on neuropsychological measures 
may not always correlate with severity of self-reported cognitive concerns. Depressive 
symptoms in HIV may influence one’s subjective report of cognitive functioning, 
creating the potential for misdiagnosis or inappropriate treatment. To improve our 
theoretical understanding and treatment of HAND, further study is needed to identify the 
associations between cognition and co-occurring factors such as recent alcohol use and 
depression. We administered a neuropsychological battery and examined whether level of 
drinking and self-reported measures of cognition would correspond with objective 
neuropsychological test performance. We also sought to address the previous finding that 
depressive symptoms can influence both objective performance and an individual’s self-
appraisal of neurocognitive problems in HIV. The primary goal of the study was to 
determine whether a cognitive self-report measure corroborates aspects of objective test 
data, or whether it may underscore psychiatric distress that is contributing to negative 
self-appraisal and functional impairment.  
 The aims and hypotheses of this study address neurocognitive factors within a 
sample of HIV+ drinkers across three overarching domains: objective performance 
(scores on a battery of neuropsychological tests), subjective self-appraisal of cognitive 
functioning on a self-report measure commonly used for persons with HIV+ (Person’s 
Assessment of Own Functioning Inventory; PAOFI), and clinical impairment 
(determined using norms provided by CogState, Ltd.).  We examined level of recent 
drinking in relation to cognition. We also examined whether other 
demographic/psychiatric variables were associated with both objective and subjective 
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scores in our sample. Lastly, CogState test scores and existing CogState normative data 
(previously collected from a healthy control population) were compared to detect patterns 
of clinically significant impairment associated with co-occurring HIV and alcohol use. 
 
1.9 Aims & Hypotheses 
Aim 1 – Examine Cognition in Relation to Quantity of Recent Alcohol Use: To 
examine cognitive status as it relates to participants’ recent drinking behavior. 
Hypothesis 1: Performance on tasks of complex executive functioning (an impulsive 
decision making task and a maze-learning task) and memory (verbal list-learning task, 
delayed recall task, and visual recall task) will vary in relation to recent drinking 
behavior. Specifically, scores on these three tasks will be negatively associated with the 
overall amount of drinking in the past three months. In addition to examining the impact 
of recent drinking, other potential correlates of cognitive performance will be explored 
(age, years of education, depressive symptoms, verbal IQ). 
Aim 2 – Examine Self-Appraisal of Cognitive Problems: To determine demographic 
and psychiatric variables associated with self-reported cognitive problems, and to 
characterize the relationships between neuropsychological task performance and self-
reported cognitive problems. 
Hypothesis 2: Neuropsychological performance will show moderate associations with 
subjective cognitive problems, which will be measured by self-report subscales (memory, 
executive functioning, and impulsivity). Specifically, subjective memory complaints will 
show a significant, negative correlation with memory performance on a verbal memory 
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task (Shopping List Task), in which individuals reporting more memory problems will 
demonstrate lower memory scores. Likewise, self-reported complaints in the domain of 
executive functioning will be moderately associated with performance on a complex 
executive function task (GMLT), in which individuals reporting greater executive deficits 
will demonstrate more errors on the maze learning task. Lastly, higher scores on a self-
report measure of impulsivity will be moderately, positively associated with 
disadvantageous decision making on the Iowa Gambling Task (IGT).  
Depressive symptoms are expected to be positively associated with self-reported 
cognitive problems across all domains. Other potential correlates of self-reported 
cognitive problems will be explored (age, years of education, verbal IQ). 
Aim 3 – Establish an Objective Cognitive Profile: To describe, using the CogState 
battery, the overarching cognitive profile in our sample. We will examine mean test 
performance by averaging individual z-scores in each cognitive domain. The z-scores 
will be calculated using normative data that were previously collected from healthy 
controls by CogState Ltd. 
Hypothesis 3: Based on average z-score, our sample will show the greatest degree of 
normative weakness on the GMLT, as this task involves several aspects of complex 
executive functioning, including sustained attention, planning, error detection, and 
learning.  
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2. Methods 
2.1 General Design 
This study utilized a cross-sectional design. Data collection consisted of a single 
visit during which participants underwent a diagnostic interview, completed self-report 
measures, and were administered a cognitive test battery that consisted of CogState tasks 
plus the Iowa Gambling Task. 
 
2.2 Participants  
A total of 122 men and women seropositive for HIV were enrolled in the study. 
Individuals were recruited through advertisements and by collaboration with physicians 
in the University of Pennsylvania Health System. Recruitment methods included referrals 
to the Treatment Research Center, posting of recruitment materials in community HIV-
treatment centers throughout Philadelphia, and through advertisements in local media. 
The research team was also granted access to a patient database maintained by the 
University of Pennsylvania Center for AIDS Research (CFAR), which included the 
contact information of seropositive individuals who provided written consent to be 
contacted for future research studies. All recruitment methods were approved the 
University of Pennsylvania IRB. 
2.2.1 Inclusion and Exclusion Criteria 
Participants were required to be 18-70 years old, currently taking HAART 
medication, and to have consumed alcohol in the past 90 days. Specific parameters of 
HIV disease (viral load, time since infection, risk group) were not assessed. Participants 
were required to have a verbal IQ of 80 or higher. Additionally, all participants produced 
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a breath alcohol reading of 0 at the time of their study visit. Each participant provided 
written informed consent to take part in the study.  
Individuals were excluded from the study if they met clinical criteria for a severe 
psychiatric illness (i.e., psychosis, mania, active suicidality) on the basis of history or 
psychiatric examination, or a current DSM-IV diagnosis of illicit drug abuse or 
dependence other than marijuana. To eliminate confounding effects of psychotropic 
medications, individuals taking antipsychotic, mood stabilizing, or sedative/hypnotic 
medications were ineligible to participate. Lastly, individuals with significant cognitive 
impairment (defined as a score of 24 or below on the Mini Mental State Exam dementia 
screening tool; Folstein et al., 1975), traumatic brain injury, or an otherwise confounding 
neurological disorder (e.g., seizure disorder) were excluded.  
 
2.3 Procedures 
2.3.1 Participant Flow through Study 
Participants first underwent a phone screening interview to assess basic inclusion 
and exclusion criteria. Participants who on telephone screening appeared to be eligible 
were invited for the in-person study visit. After informed consent was obtained, 
participants were interviewed by the research assistant, who also administered and 
supervised neuropsychological testing.  Participants who were excluded at any point in 
the recruitment process were referred for appropriate treatment based upon consultation 
with the study physician. All study visits took place at the University of Pennsylvania 
Treatment Research Center. Participants were compensated for their time and 
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transportation. Individuals were compensated $30.00 for completion of the study and 
received 1 SEPTA token (valued at $1.55) for their travel. 
2.3.2 Psychological/Behavioral Assessments 
 Sociodemographic Information: This information was obtained at baseline via 
clinical interview. Information collected included age, gender, race/ethnicity, 
household income, years of education, and marital status. 
 
 Reading Ability and General Intellectual Function: The Wechsler Test of Adult 
Reading (WTAR; Pearson Education, Inc.) is a 50-item reading test comprised of 
irregular words of increasing difficulty. Administration time is approximately 2 
minutes. WTAR reading score and demographic information (age, gender, race, 
years of education) are applied to a normative chart in the manual to obtain an 
estimated full-scale IQ. 
 
The Mini Mental State Exam (MMSE; Folstein et al., 1975) was used to screen 
for dementia and significant cognitive impairment. The MMSE provides a 5-
minute screening of cognitive capability in the domains of orientation, expressive 
and receptive language, memory, and constructional praxis. Significant cognitive 
impairment was defined as a score of 24 or below, and individuals scoring in this 
range were excluded from the study. 
 
 Psychiatric Diagnosis:  The Mini International Neuropsychiatric Interview 
(M.I.N.I) was used at baseline to classify participants according to the presence or 
27 
 
absence of standard psychiatric disorders according to DSM-IV (American 
Psychiatric Association, 1994), to determine eligibility for the study. The modules 
administered were: mania, psychotic disorders, suicidality, and drug dependence. 
 
 Recent Alcohol Use:  The Timeline Followback (TLFB; Sobell & Sobell, 1992) 
is a brief assessment method (10-15 minutes) in which retrospective estimates of 
daily drinking are obtained. It was used in the present study to estimate alcohol 
consumption and drinking patterns in the 90 days prior to the study visit.  When 
completing the TLFB calendar, participants are provided a number of recall aids 
to facilitate accurate reporting, such as a review of recent holidays and significant 
anchor events (e.g., hospitalizations, news events, birthdays), as well as 
identification of consistent drinking patterns (e.g., weekday vs. weekend). 
Participants were educated on the beer, wine, and liquor equivalents of 1 standard 
drink during phone screening and during their study visit. Previous studies 
conducted by this research team have used the TLFB effectively. It demonstrates 
high test-retest reliability and construct validity in the context of alcohol use 
(Sobell & Sobell, 1992), and moderate to high correlations with verifiable daily 
data among various substance use populations (Searles et al., 2000; Toll et al., 
2005). 
 
 Recent Cannabis Use and HAART Medication Adherence: The TLFB (Sobell & 
Sobell, 1992) was also used to elicit retrospective self-reports of cannabis use and 
degree of adherence to HAART medication in the 30 days prior to the study visit. 
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Summary measures for cannabus were the number of days on which cannabis was 
used, and the estimated total amount (number of joints) used. For medication 
adherence, the total number of days with 100% adherence and overall percentage 
of adherence in the past month were recorded.  
 
 Depressive Symptoms: The Patient Health Questionnaire (PHQ-9; Kroenke & 
Spitzer, 2002) is a well-validated self-report measure that includes 9 standard 
diagnostic items for depression. It requires a shorter administration time than the 
Beck Depression Inventory-II, and thus is often used in primary care and brief 
screening settings. It is sensitive to changes in depressive symptoms, including 
suicidal risk, and can classify individuals into 5 categories: no/minimal 
symptoms, mild symptoms, moderate symptoms, moderately severe symptoms, 
and severe symptoms. 
2.3.3 Cognitive/Neuropsychological Testing 
We administered seven subtests of the CogState battery, which was provided free 
of charge by CogState Ltd. for research purposes. CogState is a computerized assessment 
battery recently found to be sensitive to cognitive impairment in individuals with HIV 
who did not have dementia (Overton et al., 2011). In that study, a total of 46 HIV-
infected persons underwent both formal paper-and-pencil neurocognitive testing and 
CogState testing. CogState scores correlated with traditional neuropsychological testing, 
and associations were strongest for simple detection tests (e.g., Detection Task). 
Regression analysis indicated that 53% of the variance in a composite Global Deficit 
Score was accounted for by elements of the CogState battery (Overton et al., 2011).  
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General psychometric aspects of the battery have been evaluated in several 
studies. Maruff et al. (2009) investigated the validity of using the CogState battery in lieu 
of traditional, paper-and-pencil testing. In a large group of healthy adults, CogState 
measures of processing speed, attention, working memory, and learning showed 
moderate to high correlations with traditional neuropsychological counterparts in the 
same domains (range: r = .49 to .83). The researchers also evaluated the battery among 
clinical subgroups, including individuals with mild head injury, schizophrenia, and AIDS 
dementia complex. Each of these groups was identified as impaired on the CogState 
performance measures (range: Cohen's d = -.60 to -1.80), with similar qualitative and 
quantitative patterns observed within each group. The report concluded that the CogState 
battery has acceptable construct and criterion validity in the context of 
neuropsychological testing, and thus may be of clinical utility in the HIV/AIDS 
population (Maruff et al, 2009). 
 CogState Battery: 
Detection Task (Psychomotor Speed/Reaction Time) [2 minutes].  For this test, 
participants must press a response key as soon as they detect a stimulus (a playing 
card switching from face-down to face-up). The software measured the response 
time to detect each event.    
Identification Task (Basic Attention) [3 minutes].  In this task an event occurs in 
the center of the computer screen (card turns face up) and the participant must 
decide whether the event meets a predefined and unchanging criterion (whether 
the suit on the card is red).  The software measured the accuracy of each response.  
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One-Back Memory Task (Working Memory) [1 minute]:  On this task the 
participant is shown a single stimulus in the center of the computer screen (card 
turns face up). They must decide whether the current card matches the card seen 
on the immediately previous trial. The software measured the accuracy of each 
response. 
Shopping List Task – Immediate and Delayed Recall Trials (Verbal Learning and 
Memory) [5 minutes]: Participants were read a list of 12 words at the rate of one 
word every 2 seconds. After the list was completed, the participant was asked to 
recall as many of the words as possible. This process was repeated for a second 
and third trial. After a 20-30 min delay, the participant was again asked to recall 
as many words as possible, without being read the list again. Total number of 
words recalled at initial recall (T1 + T2 + T3) and delayed recall comprised the 2 
outcome scores for this task. This format is similar to a number of commonly 
used paper-and-pencil neuropsychological tasks of verbal learning and memory, 
including the California Verbal Learning Test and the Hopkins Verbal Learning 
Test. 
Card Learning Task (Visual Learning and Memory) [5 minutes]: This is a 
continuous visual memory task in which playing cards are displayed on the screen 
one at a time, and participants were asked to indicate “Yes” or “No” as to whether 
they had seen the card before during the present task. Several target cards were 
repeated throughout. The software measured the accurary of responses. 
Groton Maze Learning Test (GMLT) (Executive Function) [5 minutes]:  
Participants were shown a 10 x 10 grid of tiles on the computer screen, in which a 
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28-step pathway is hidden among the 100 possible locations, with the start and 
finish locations in the top left and bottom right of the grid, respectively. Each 
participant was instructed to move one step from the start location and to 
continue, one tile at a time, toward the end. The participant moved by clicking the 
mouse on each desired tile. After each move, the computer indicated whether it 
was correct or incorrect.  If the choice was incorrect, the participant was required 
to return to the last correct location and then make a different tile choice to 
advance toward the end.  While moving through the hidden maze, participants 
were required to adhere to two rules: no diagonal moves or touching the same tile 
twice in succession and no moving backwards along the pathway. Thus, the 
participants learned the 28-step pathway though the maze on the basis of this trial 
and error feedback.  Once completed, the same maze was completed for 4 more 
trials, offering individuals the chance to improve if they could learn the pathway 
just completed. The software measured the total number of errors across all 5 
trials. According to a report by Pietrzak et al. (2008), the GMLT demonstrates 
construct validity as a measure of executive functioning, but also incorporates 
aspects of visuospatial capabilities. Exploratory factor analysis indicated a two-
factor solution of error monitoring and spatial learning efficiency. These findings 
suggest that the GMLT captures the executive elements of problem solving and 
error monitoring, while also requiring visuospatial learning. 
To determine the overall objective level of impairment in our sample, we also 
interpreted CogState test scores in relation to existing normative data that were 
previously collected in studies by other research groups. The CogState normative 
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dataset was collected between 2009 and 2012, and these data were provided to the 
study team by CogState Ltd. The normative sample represents data from a healthy 
population of adults aged between 18 and 89 years. The sample was formed on 
the basis of aggregated data from subjects enrolled in a series of clinical trials and 
academic studies, with participants recruited from North and South America, 
Europe, Asia and Australia. The norms were divided into age bins incorporating 
individuals aged 18-34, 35-49, 50-59, 60-69, and 70-79. Using the population 
mean and standard deviation provided for each CogState task, we created age-
adjusted z-scores for every participant within each of the cognitive domains 
assessed in the current study. 
 
 Iowa Gambling Task (IGT): The IGT (Bechara et al., 1994) is a non-CogState 
task that was added to the battery. It is a computerized gambling task intended to 
simulate real-world decision making. In this task, the participant begins with 
$2,000 of “play” money and is instructed to maximize profit over 100 trials by 
selecting cards from any of four decks. Based on profit and loss potential, two of 
the decks are termed “advantageous” and two are “disadvantageous.” Outcome 
measures included the overall difference between total advantageous and total 
disadvantageous selections across over five 20-card blocks.  
 
 Self-Report Cognitive Questionnaire (PAOFI): In addition to collecting objective 
neuropsychological data, we collected subjective data using a self-report 
questionnaire of cognitive problems. Individuals rated their perceived impairment 
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in tasks related to attention, executive function, memory, psychomotor speed, and 
decision-making. This checklist was a modified version of the assessment 
currently used by the HIV Neurobehavioral Research Program at UCSD (e.g., 
Heaton et al., 2004), the Person’s Assessment of Own Functioning Inventory 
(PAOFI; Au et al., 2008). The assessment was modified to include an additional 
subscale capturing impulsivity. The impulsivity scale added to the PAOFI was the 
“impulsive urgency” subscale of the UPPS-P Impulsivity Scale (Lynam et al., 
2006). Each item pertains to impulsive decision-making in response to unpleasant 
mood states (e.g., “When I am upset, I often act without thinking.”). Questions are 
scored on a Likert scale from 1 (Agree Strongly) to 4 (Disagree Strongly). This 
scale was selected based on a previous neuropsychological study that found a 
significant association between higher impulsive urgency score and more 
disadvantageous decision making on the Iowa Gambling Task (Zermatten et al., 
2005).  
 
3. Results 
 
3.1 Recruitment & Exclusions 
 
The University of Pennsylvania Center for AIDS Research (CFAR) database 
accounted for 51.2% of the individuals who made initial contact with the study team. 
Other recruitment sources included Philadelphia Fight at the Jonathan Lax Center (5.5%), 
direct referral from University of Pennsylvania Health System medical providers (4.9%), 
word of mouth (4.2%), flyers posted at Penn-Presbyterian Hospital and Hospital of the 
University of Pennsylvania (3.7%), flyers posted in the community (3.5%), and Action 
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AIDS (2.3%).  Less successful avenues of recruitment were Craigslist, advertisements in 
Philadelphia Gay News, and the Northeast Times newspaper, which accounted for less 
than 2% of study contacts. An additional 19.3% of prospective participants did not report 
(or were unsure) where they had heard about the study. In total, the study team made 
phone contact with 842 prospective participants. Of those 842 individuals, 242 did not 
respond to additional phone outreach attempts and 107 declined to participate after 
hearing a brief description of the study protocol, resulting in 473 individuals who agreed 
to be screened by phone. A total of 259 people did not meet eligibility criteria on phone 
screening (See Table 2, Column 1), and another 35 met criteria but did not attend their 
scheduled study visit. Thus, 179 individuals attended the study visit, and 124 out of 179 
were eligible for participation and completed the study (See Table 2, Column 2). The two 
most common reasons for exclusion upon phone screening were current use of an 
exclusionary medication (mood stabilizers or sedative/hypnotics) and answering 
positively on screening items for illicit drug dependence. At the time of the study visit, 
participants were most commonly excluded on the basis of self-reported current drug 
dependence on the MINI and WTAR verbal IQ below average limits (<80).  
Data collected from 122 participants were included in the present analyses. 
Although 124 participants completed the study, a software error resulted in failure to 
collect CogState data for two participants, and those individuals were excluded from the 
analyses. Additionally, 12 participants did not have recorded data for the Iowa Gambling 
Task due to a test administrator error. Data from these individuals were included only in 
statistical analyses that did not involve the Iowa Gambling Task. 
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3.2 Characteristics of Sample 
For a full description of the sample, see Table 3. Participants ranged in age from 
21 to 66, with a mean age of 47 (SD = 10.1). The sample was predominantly male (n = 
103; 84%), and most individuals self-identified their primary race as African-American 
(n = 88; 72%). The remainder of the sample was comprised of European-American (n = 
29; 24%), Hispanic (n = 3; 3%), and Filipino (n = 1; 0.8%) individuals.  Participants had 
completed a mean of 14 years of education (SD = 2.6), and mean verbal IQ score was 
within the average range (M = 97; SD = 13.0). As mentioned above, verbal IQ below 80 
was an exclusion criterion for the study.  
Drinking behavior was assessed via self-report on the Timeline Followback 
(TLFB), and retrospective 90-day ratings were summarized into four variables: total 
number of standard drinks consumed, number of drinking days, number of heavy 
drinking days, and average number of drinks per drinking day. Although distinct, these 
four variables showed very high associations with one another. Two clinically important 
indicators, number of standard drinks and number of heavy drinking days demonstrated 
the highest correlation (r = .82).  Our sample was comprised primarily of low-level 
drinkers, though individuals who engaged in moderate and very heavy drinking were also 
represented. For the sample as a whole, the mean number of drinks per drinking day was 
5 (SD = 4.4), with an average of 36 drinking days (SD = 27.8) in the 90-day timeframe 
prior to the study visit. The mean number of heavy drinking (HD) days was 16 (SD = 
24.3), although 38% of the sample (n = 46) reported only 0 or 1 HD days in the past 3 
months. Self-reported cannabis use in the sample was low: 63% of the sample reported 
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no cannabis use in the previous month, and 86% of participants reported using on five 
days or less. Only six individuals reported daily use of cannabis. 
Self-reported HAART medication adherence averaged 94% (SD = 10.1). Of note, 
rates of medication adherence were significantly negatively correlated (p-values < 0.01) 
with PHQ-9 depression score (r = -.35), self-reported impulsivity (r = .35; lower score 
reflects greater impulsivity), self-reported cognitive problems with memory/executive 
functioning (r = .26; lower score reflects more cognitive problems), and number of heavy 
drinking days in the past 3 months (r = -.34. Amount of cannabis use was not associated 
with medication adherence in our sample. In terms of depressive symptoms, most 
participants scored at very low levels on the PHQ-9. Specifically, 86% of the sample 
scored in the minimal or mild range of depression, 8% scored in the moderate range, 4% 
scored in the moderately severe range, and only 1.6% of participants scored in the 
severely depressed range. The mean PHQ-9 score was 4.6 (SD = 5.0).  
 
3.3 Correlations between Cognitive Tasks 
 
The correlation matrix for all neuropsychological test scores is shown in Table 4. 
In addition to the Pearson correlations listed, these data were also compared via visual 
inspection using scatterplots and histograms to ensure the validity of significant 
associations. An in-depth factor analysis of constructs underlying neuropsychological 
task performance was not feasible in the present study due to limitations in statistical 
power. However, the small to moderate magnitude of correlations among the CogState 
tasks suggests that each score in this battery captures a unique aspect of 
neuropsychological functioning, and thus each outcome measure was interpreted as an 
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independent construct in subsequent analyses. Not surprisingly, the strongest correlation 
among the cognitive tasks was between the immediate and delayed verbal memory trials 
on the Shopping List Task (r = .71).   
Notably, total error score on the Groton Maze Learning Task, the primary 
measure of executive functioning in this study, showed significant small-to-moderate 
correlations with nearly all other cognitive domains. Greater accuracy on CogState tasks 
of psychomotor speed, working memory, visual memory, and initial verbal learning were 
all associated with stronger executive performance on the GMLT. The Iowa Gambling 
Task (IGT), a non-CogState measure of impulsive decision-making, also showed 
significant associations with attention and executive function (GMLT) performance in 
our sample. The small but significant correlation between the IGT and GMLT was 
expected, as the IGT and the GMLT are regarded as “higher-order,” complex executive 
tasks, and both are purported to capture functioning of the prefrontal cortex.  However, 
the correlation was in the opposite of the expected direction, suggesting that individuals 
who performed better on the maze learning task (by making fewer errors) actually 
demonstrated more disadvantageous decision-making on the IGT.   
Two other findings were observed regarding interpretation of attention 
(Identification Task) and working memory (One-Back Task) scores. First, performance 
on these two similar constructs did not show any significant correlation with one another. 
Second, verbal IQ (from the WTAR) was not significantly related to attention or working 
memory scores. Potential explanations for these effects follow in the Discussion. 
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3.4 Alcohol Use and Cognitive Performance (Aim 1 / Hypothesis 1) 
The data were examined for potential relationships between cognitive 
performance and level of drinking using multiple regression analyses. Quantitative 
measures of alcohol use were winsorized to meet statistical assumptions of normality and 
to minimize the influence of outliers. The primary score from each of the eight 
neuropsychological tasks was entered as a dependent variable into a multiple regression 
analysis to determine which tasks, if any, were significantly influenced by level of 
alcohol use (independent variables: total number of drinks, number of drinking days, 
mean number of drinks per drinking day, and number of heavy drinking days). The 
analysis showed that no tasks were selected for inclusion in the regression model for 
alcohol use and cognitive performance.  
Visual inspection of scatterplots and examination of correlation coefficients did 
not support a linear relationship between objective cognitive performance and any of the 
TLFB alcohol summary variables. In fact, the magnitude of correlations was below .10 
for most bivariate comparisons. The largest correlations were observed between number 
of HD days and immediate verbal memory on the Shopping List Task (r = .17), as well as 
number of HD days and executive functioning on the GMLT (r = .15), though these 
associations were not statistically significant.  
To identify potential non-linear relationships between alcohol use and cognitive 
performance that were not detected by multiple regression, we divided our sample into 
two groups by recoding a subset of participants at the lowest extreme of drinking and the 
highest extreme of drinking. Groups were operationalized based on a clinically 
informative indicator, number of heavy drinking days (defined by the National Institute 
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on Alcohol Abuse and Alcoholism as >3 drinks/day for women and >4 drinks/day for 
men). We then used ANOVAs to compare mean cognitive scores between the two 
extreme groups: Light Drinkers (LD group; comprised of the 28 individuals who reported 
no heavy drinking days in the 90 days prior to their study visit) versus Heavy Drinkers 
(HD group; 30 individuals who reported an average of 2 heavy drinking days per week, 
i.e., 25 heavy drinking days or more in the past 90 days). We found that the groups 
differed significantly on demographic and psychiatric variables, as shown in Table 5. The 
HD group was characterized by fewer years of education, lower IQ, greater depression 
scores, more frequent cannabis use, lower HAART adherence, and a higher proportion of 
African-American participants (2 = 12.7, p = .005). The groups did not differ 
significantly in age. A series of one-way ANOVAs for each cognitive task revealed a 
significant cognitive difference between the LD group and HD group on the immediate 
recall trial of the Shopping List Task, a measure of verbal learning. The mean number of 
words recalled, summed over 3 learning trials, was lower in the HD group (M = 23.4; SD 
= 4.3) than in the LD group (M = 25.6 SD = 3.7) [F(1,57) = 4.55; p = 0.04]. The size of 
this effect was moderate (η2 = 0.07). 
 
3.5 Self-Reported Cognitive Concerns and Cognitive Performance (Aim 2 / Hypothesis 2) 
Self-appraisal of cognitive complaints was determined via scores on three 
subscales of the modified Person’s Assessment of Own Functioning Inventory (PAOFI). 
Each of the three indices (memory, executive function, and impulsivity) is a total score 
representing the sum of Likert ratings for each item. Lower scores are indicative of more 
perceived problems. As shown in Table 6, we found that all 3 self-report subscales of the 
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PAOFI were highly significantly correlated with one another (r = .61-.76). A high 
prevalence of mild memory concerns was evident in our sample. Only 3 of 122 
participants rated themselves as having no subjective memory complaints on the 10-item 
memory subscale (e.g., forgetfulness, misplacing items), whereas 17 of 122 participants 
rated themselves as having no executive function complaints on the 9-item executive 
function subscale (e.g., problem-solving, distractibility). Thus, almost all participants 
(98%) reported some difficulty with memory, and the majority (86%) reported at least 
one executive function complaint.  
For each participant, a summary score was created by adding together the scores 
from the memory and executive functioning PAOFI subscales. The result was a self-
reported cognitive functioning scale with a possible score range from 19 (least severe 
cognitive complaints) to 114 (most severe cognitive complaints). In the current sample, 
actual PAOFI summary score ranged from 47 to 114, with a mean score of 93.2 (SD = 
14.9). To determine whether older participants may have rated themselves as more 
impaired simply due to accurate perceptions of normal age-related cognitive changes, we 
conducted a bivariate Pearson correlation examining age in relation to PAOFI summary 
score. The correlation was small (r = .11) and statistically non-significant, suggesting that 
age was not a contributing factor to cognitive self-appraisal.  
Due to insufficient statistical power to analyze patterns in the data using canonical 
correlation, we instead utilized bivariate Pearson correlations to compare objective 
neuropsychological performance with self-reported cognitive functioning. We compared 
each domain of self-reported cognitive functioning (memory, executive function, and 
impulsivity) with its analogous objective neuropsychological test score (Shopping List 
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Task, Groton Maze Learning Task, and Iowa Gambling Task). Across all comparisons, 
self-appraisal of cognitive complaints showed no significant relationship with 
corresponding objective test performance (See Table 6). The magnitude of correlations 
between subjective rating and objective score was universally small, not exceeding a 
Pearson r value of 0.17. These findings clearly contrasted with our hypothesis that 
moderate, statistically significant correlations would be observed.  
When the influence of depressive symptoms was considered, a clear association 
with self-reported cognitive concerns (but not objective performance) was found. Most 
participants in our sample did not endorse substantial depression, resulting in a skewed 
distribution toward low levels of depression. To address skewness, PHQ-9 scores were 
winsorized prior to conducting statistical analyses. Results demonstrated that, although 
the rates of depression in our sample were low, winsorized PHQ depression score showed 
moderate-to-large, statistically significant associations with self-reported cognitive 
complaints in all three domains assessed: memory (r = -.53; p < 0.001), executive 
function (r = -.51; p < 0.001), and impulsivity (r = -.63; p < 0.001). The direction of these 
correlation coefficients indicate that individuals who endorsed more depressive 
symptoms were significantly more likely to report cognitive memory and executive 
function complaints, and also significantly more likely to rate their decision-making as 
impulsive. However, depressive symptoms were not significantly associated with actual 
objective neuropsychological performance in any domain.  
In terms of self-reported cognitive complaints and drinking behavior, notable 
associations were present with every alcohol-related variable on the TLFB. The most 
striking finding was the association between higher levels of drinking and greater self-
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reported impulsivity. Self-reported level of impulsivity score was significantly related to 
all four summary measures of alcohol use derived from the TLFB, with moderate 
associations found for number of heavy drinking days (r = -.55, p < 0.01), followed by 
total number of drinks consumed (r = -.50, p < 0.01), drinks per drinking day (r = -.44, p 
< 0.01), and number of drinking days (r = -.33, p < 0.01) (note that a lower numerical 
score reflects greater impulsivity, resulting in a negative correlation coefficient between 
high levels of impulsivity and higher levels of drinking). Self-rated PAOFI memory score 
was also significantly associated with all four summary measures of alcohol use on 
TLFB. Small correlations were observed for number of heavy drinking days (r = -.37, p < 
0.01) and total number of drinks consumed (r = -.37, p < 0.01), followed by number of 
drinking days (r = -.31, p < 0.01) and drinks per drinking day (r = -.26, p < 0.01). Lastly, 
self-rated executive functioning score on the PAOFI showed a similar pattern of 
association with the four summary measures of alcohol use, although with a smaller 
range of correlation values across the four TLFB measures (r = .21-.29). 
  
3.6 Exploring Associations of Objective and Subjective Scores 
To generate a parallel set of analyses for objective performance and subjective 
complaints, we conducted an exploratory series of multiple regression analyses. The goal 
of these analyses was to identify shared correlates of objective cognitive performance and 
subjective, self-reported cognitive concerns.  Ten dependent variables were considered: 
the 8 neurocognitive performance task scores (treated as separate dependent variables) 
and 2 self-report subscales of cognitive problems (due to the high correlation between the 
PAOFI memory and executive function scales, a combined score for these two scales was 
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used as a single dependent variable, and self-reported impulsivity was treated as a 
separate dependent variable). The independent variables considered for inclusion in the 
model were identical for all analyses: age, years of education, verbal IQ, number of 
heavy drinking days, PHQ-9 score, cannabis use, and HAART medication adherence. We 
utilized a Bonferroni corrected alpha level (p < .005) to avoid inflating the risk of Type 1 
error resulting from multiple comparisons.  
In terms of objective performance, Verbal IQ was significantly associated with 
performance on two complex prefrontal tasks, the GMLT (b = -1.3, SEb = 0.31, p = 
.0002) and the IGT (b = 0.73, SEb = 0.21, p = .001), though in both cases the effect size 
was small (adjusted r
2
 = .13 and .10, respectively). Both verbal IQ (b = .16, SEb = 0.03, p 
< .00001) and age (b =   -.10, SEb = 0.04, p = .003) were correlated with the immediate 
memory trial on the Shopping List Task, whereas only years of education (b = .28, SEb = 
0.08, p = .001, adj. r
2
 = 0.08) was correlated with performance on the delayed recall trial 
of the Shopping List Task. Again, the effect sizes were small. Linear regression did not 
reveal any significant associations between the independent variables and task 
performance in psychomotor speed, attention, or working memory. Medication adherence 
and cannabis use were not associated with objective cognitive performance in any 
domain. 
Regarding subjective complaints, the results of stepwise multiple regression 
analyses indicated that only depressive symptoms were significantly associated with self-
reported memory/executive function rating on the PAOFI. This model accounted for 29% 
of the overall variance in PAOFI score (p = .000001; adjusted r
2
 = .29). Additionally, 
depressive symptoms (p < .000001), number of heavy drinking days in the past 90 days 
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(p = .00001), and years of education (b = 0.63, SEb = 0.22, p = .005) were significant 
predictors of self-reported impulsivity and explained more than half of the variance in 
this score (adjusted r
2
 = .52). Depressive symptoms had the largest effect size within this 
model (adjusted r
2
 = .37). 
 
3.7 Mean Cognitive Performance and CogState Normative Data (Aim 3 / Hypothesis 3) 
The present study utilized a single sample of HIV+ drinkers. However, we also 
sought to compare mean performance in our sample with age-matched healthy controls, 
to determine whether overall cognitive performance reflected Below Average or Impaired 
performance. By analyzing previously collected test data provided by CogState Ltd., we 
were able to compare the current cognitive results with mean performance from a much 
larger sample of population-based norms. For every subject in our study, primary 
outcome score in each CogState domain (psychomotor speed, attention, working 
memory, visual memory, verbal learning/memory, and executive function) was converted 
to a z-score using the population-based normative data provided by CogState. Then, 
within each cognitive domain, the mean z-score and standard deviation were calculated 
for the overall sample.  
Based on the executive deficits associated with HIV (and alcohol use), we 
hypothesized that our sample would show the greatest degree of normative weakness on 
the GMLT. We suspected that because maze-learning on the GMLT involves several 
aspects of complex executive functioning, including attention, planning, and error 
detection, that these processes would be disrupted as a function of the prefrontal 
pathways believed to be adversely affected in HIV. However, as shown in Figure 1, this 
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hypothesis was not supported. The lowest mean z-score in our sample was for reaction 
time on the CogState Detection Task of psychomotor speed (M = 1.16; SD = 1.07). This 
measure of processing speed was the only cognitive task for which mean performance 
was more than 1 standard deviation below the mean. Performance on the GMLT was 
observed to be the second lowest z-score (M = 0.93; SD = 2.09), but at less than 1 SD 
below the mean, it was within average limits. In summary, these findings suggest that 
among our sample of HIV+ drinkers, there was a global pattern of very slight decline 
below normative neuropsychological performance. However, from a clinical perspective, 
mean performance on the CogState tasks analyzed did not generally fall outside of 
average limits.  
 
4. Discussion 
4.1 Summary and Interpretation of Results 
The observed distribution of gender and race/ethnicity in our sample is similar to 
that of the population of men and women currently living with HIV/AIDS in Philadelphia 
(AIDS Activities Coordinating Office, 2012). According to the 2012 surveillance report 
from the Philadelphia Department of Public Health, the majority of newly-diagnosed HIV 
infections from 2008-2012  occurred among African-Americans (59-70% of new 
infections), and new infections occurred much more commonly in men (68-77% of new 
infections) than women. In the current study, 88 of the 122 participants (60%) were 
African-American men.  These data suggest that, in terms of demographics, our sample is 
generalizable to the larger HIV population in the city. 
Recent alcohol use was not significantly associated with neurocognitive 
performance on any task in several regression analyses. Drinking behavior was associated 
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only with self-reported impulsivity. However, when groups comprised of the lightest and 
heaviest drinkers in our sample were compared, significant findings emerged. The groups 
differed cognitively on verbal memory performance, as well as on several 
sociodemographic and psychiatric variables. In terms of demographics, members of the 
HD group were less educated, had lower verbal IQ, higher PHQ-9 depression scores, and 
were more likely to be African-American. The HD group also endorsed more self-rated 
impulsivity traits, and more complaints related to memory and executive functioning. 
Most notably, mean performance on the Shopping List Task (SLT; verbal memory) was 
significantly lower in the HD group. This finding partially supported our original 
hypothesis; heavy drinkers had greater difficulty with verbal learning over a three-trial 
learning period, but did not differ significantly from the LD group on the delayed recall 
of the task. In general, this finding is supportive of prior literature indicating an adverse 
effect of heavy alcohol use on cognition in HIV. More specifically, the difference 
between groups may reflect a less efficient encoding process among the HD individuals, 
possibly resulting from subtle temporal and/or prefrontal abnormalities. Specific 
cognitive processes, such as mechanisms of learning and memory, should be examined in 
future studies of HIV+ heavy drinkers. 
We found a significant association between depression scores and self-reported 
cognitive problems, but no associations between depression and objective task 
performance. It should be noted, however, that most of the sample did not fall within a 
clinically significant range of depression. A regression model predicting self-reported 
impulsivity showed that PHQ-9 depression score, number of heavy drinking days in the 
past 3 months, and years of education accounted for 52% of the variance in impulsivity 
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score. Assessment of impulsive behavior will be particularly important in the context of 
HIV and alcohol addiction research, as impulsivity likely plays a causal role in both 
conditions. Research suggests that impulsivity is a predisposing risk factor associated 
with a younger age of first alcoholic drink, greater likelihood of developing an alcohol 
use disorder, and a more severe clinical course in terms of alcohol-related functional 
impairment (Lejuez et al., 2010). Likewise, risk-taking and impulsive decision-making 
predict greater likelihood of becoming infected with HIV (Bornovalova et al., 2008; 
Shuper et al., 2010). Our findings supported the notion that impulsivity, alcohol use, and 
depressive symptoms have a negative association with adherence to HAART medication 
in HIV+ individuals. Together, the present study underscores the link between self-
reported impulsivity and drinking in HIV, and suggests a potential relationship between 
impulsivity and depressive symptoms. Our analyses did not support drinking-related 
differences in objective cognitive performance on a decision-making task (IGT), a 
finding that is inconsistent with prior research in HIV populations.  
Lastly, the overall pattern of CogState test results for our sample demonstrated 
that neuropsychological performance was mostly within average limits. This limited 
variability may have been attributable to our selection parameters for cognition (MMSE > 
24 and WTAR VIQ ≥ 80). Alternatively, viral infection among the HIV+ men and 
women in our sample may have been optimally managed by HAART, thereby protecting 
individuals against cognitive decline. Taken together, these performance means do not 
meet the objective performance criterion for even the mildest form of HAND 
(asymptomatic neurocognitive impairment; see Table 1), which requires impaired 
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neuropsychological functioning in 2 or more domains. This suggests that the breadth and 
magnitude of cognitive deficits in our sample was relatively small. 
Overall, the present results support the notion that subjective cognitive complaints 
in HIV are more strongly associated with co-occurring psychiatric variables (depressive 
symptoms and alcohol use) than with objective cognitive test scores. Our results support 
prior literature asserting that individuals’ subjective experience of their cognitive 
performance may provide a different picture than traditional neuropsychological 
assessment. Biases in self-report approaches could make it difficult for providers to 
assess the everyday functioning criterion necessary for HAND diagnosis. Thus, a 
multimodal assessment may be best. Clinical methods to enhance assessment may 
include eliciting specific examples of functional impairment during clinical interviewing, 
inquiring about level of depression and perceived mood-related changes in cognition, 
requesting supplemental reports from spouses or caregivers, and directly observing an 
ecologically-valid performance or behavior (e.g., driving simulator, medication 
management task). Future research should also address whether individuals with a poorer 
self-appraisal of cognitive function actually shower greater functional impairment in 
daily life than those who do not perceive such deficits. Though the PAOFI addresses the 
nature and extent of subjective cognitive problems, it does not address the perceived 
degree of functional impairment associated with each problem endorsed. 
Both the level of alcohol consumption and severity of depressive symptoms were 
significant contributors to perceived cognitive problems in this sample. The importance 
of acknowledging psychiatric distress and drinking behavior in HIV was highlighted in a 
recent study comparing neurocognitive performance and self-reported psychiatric distress 
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between a group of 46 adults at the acute and early stages of HIV infection (AEH) and 21 
demographically-matched seronegative patients (Weber et al., 2013). The AEH 
participants were five times more likely than the non-HIV group to report anxiety and 
depression. Within the AEH sample, higher levels of anxiety and depression were 
associated with high-risk alcohol use (Weber et al., 2013). In future studies, depression 
may warrant exploration as a mediator of the observed relationship between alcohol use 
and perceived cognitive problems/functional impairment. 
Because levels of alcohol use and depressive symptoms were under-represented in 
the sample, it is not clear whether these findings also generalize to clinical populations. 
Participants in the current study were volunteers who obtained no direct health or 
treatment benefit, and thus recruitment efforts may not have been successful for more 
severely depressed or functionally impaired individuals with HIV. In an attempt to limit 
confounding variables, we intentionally excluded participants with more severe mental 
health comorbidities. As shown in Table 2, a large proportion of prospective participants 
were excluded on the basis of drug dependence, bipolar disorder, or use of certain 
psychotropic medications (benzodiazepines or mood stabilizers). Although the etiology 
of cognitive dysfunction is difficult to disentangle in such cases of complex comorbidity, 
perhaps including dual-diagnosis patients would have provided a more comprehensive, 
externally-valid representation of HIV+ drinkers.  
 
4.2 CogState Battery 
The CogState battery was a useful tool for comprehensive neurocognitive 
assessment in this study. Computerized testing was quick and efficient to administer, and 
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provided detailed and precise measures of cognitive performance across multiple 
domains. Administrator errors were minimized via electronic scoring. Measurement was 
automated and precise, and data were directly downloadable into spreadsheet form. More 
importantly, CogState performance was sensitive enough to detect mean cognitive 
differences between our sample and a large normative database of healthy controls. 
Although mean z-scores for our sample were mostly within Average limits (within 1 
standard deviation), there was an overall trend toward Below Average performance.  
Greater accuracy on CogState tasks of psychomotor speed, attention, working 
memory, visual memory, and initial verbal learning were all associated with stronger 
executive performance on the GMLT. These findings are consistent with previous 
research suggesting a learning and memory component involved in mastery of the GMLT 
(Pietrzak et al., 2008). These findings also support the use of the GMLT as a complex 
executive functioning task that relies on more basic cognitive processes (e.g., sustained 
attention over 5 trials).  The small but significant correlation between the GMLT and the 
IGT was predicted, as both are purported to capture functioning of the prefrontal cortex.  
However, the correlation was in the opposite of the expected direction, suggesting that 
individuals who performed better on the maze learning task (by making fewer errors) 
actually demonstrated more disadvantageous decision-making on the IGT. The distinct 
constructs underlying performance on these higher-order executive tasks (GMLT and 
IGT) warrant further exploration in a larger sample. 
Attention and working memory scores on CogState did not show any correlation 
with one another in our sample. Traditional neuropsychological measures of attention and 
working memory generally share significant overlap, and so the lack of association found 
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in the present study is surprising. The discrepancy in this case may reflect the distinct 
outcome variables used to measure these constructs in the CogState software (reaction 
time for the attention task vs. overall accuracy for the working memory task).  
 
4.3 Clinical Intervention and Future Directions  
Although average cognitive performance was not significantly below the healthy 
population mean (as determined by CogState normative data) in our sample, avenues for 
rehabilitation are needed for individuals who suffer from HIV-related cognitive 
impairment and co-occurring alcohol use disorders (Weber et al., 2013). Alcohol can be 
associated with cognitive decline in HIV via a direct pathway involving chronic 
neurotoxicity (Fernandez-Serrano et al., 2011), but also via an indirect pathway triggered 
by non-adherence to antiretroviral medications (Samet et al., 2004). Active alcohol use is 
consistently one of the strongest predictors of poor compliance with HAART (review by 
Altice et al., 2010), and non-adherence to HAART is associated with decreased CD4 
count and increased viral progression, which may cause further declines in cognitive 
functioning. Without intervention, the cycle is perpetuated as cognitive processes become 
more impaired, and adherence may subsequently decline even further. The indirect 
pathway (non-adherence to HAART leading to immunosuppression and viral 
progression) should therefore be prioritized as a key point of clinical treatment for HIV+ 
drinkers, ideally through (1) cognitive compensatory strategies to promote adherence and 
(2) targeted addiction recovery treatment to reduce alcohol consumption  (Persidsky et 
al., 2011; Weber et al., 2013).  
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Beyond the individual health benefits associated with decreased drinking and 
increased HAART adherence, there is perhaps an even more important public health 
benefit involving the epidemic of HIV infection. Alcohol and drug use drives a large 
proportion of HIV transmission through increased likelihood of risky sexual behavior and 
shared injection drug use equipment (Samet et al., 2007). Reducing drinking (and drug 
use) can therefore be considered HIV prevention in two important ways (Metzger et al., 
2010). First, for HIV+ men and women who drink, reducing alcohol consumption to safe 
levels makes it less likely that HIV will be transmitted to others through risky behavior. 
Second, effective alcohol and drug treatment acts as HIV prevention by increasing the 
likelihood of adherence to HAART and achieving the desired virologic response to 
medication (Metzger et al., 2010; Samet et al., 2004). With sustained viral suppression, 
the chances of HIV transmission are further reduced (DeCock et al., 2009; Lima et al., 
2008). From both individual and public health perspectives, strategies to reduce drinking 
and promote consistent medication adherence are clearly needed, and must remain a 
frontline research and clinical focus in HIV. 
 
4.4 Limitations  
 
The primary limitations in this study concern threats to internal validity of the 
statistical analyses described above. These were not anticipated; they occurred after the 
changes in study design, and were only made due to our inability to recruit an adequate 
number of HIV+ heavy drinkers to participate in an alcohol treatment trial aimed at 
helping them to reduce their drinking. The study was initially conceptualized as a clinical 
trial in which drinking, cognitive performance, and CD4 count/viral load would be 
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prospectively monitored (in an active alcohol treatment group and a placebo group) over 
a 12-week period. Instead, the present findings were limited to correlations between 
measures administered at a single study visit. The cross-sectional nature of data 
collection did not allow for inferences of causality and there is a lack of clarity regarding 
the temporal ordering of variables chosen as predictors and outcomes. Another limitation 
is that the findings were derived from a single sample of HIV+ drinkers. Although we 
divided a portion of our sample into light drinkers and heavy drinkers to conduct 
ANOVAs, there was no healthy control group of non-drinkers or seronegative patients 
against which scores could be compared. To partially address this limitation, we 
compared overall patterns in CogState performance to a large sample of normative data 
collected from healthy individuals.  This comparison provided preliminary information 
on the broad cognitive picture of HIV+ men and women who drink alcohol in relation to 
a non-HIV population, which may be of interest in clinical neuropsychological settings.  
A second factor limiting internal validity is potential heterogeneity in viral factors 
in the sample (i.e., disease course and severity). It is possible that the significant findings 
in our study may be attributable to other factors, such variability in HIV progression that 
was not detected. Study participants were not assessed for HIV-related markers such as 
CD4 count, viral load, or number of years since infection, meaning that the influence of 
immunosuppression and/or uncontrolled neurotoxic processes may have confounded our 
current results.  To support our conclusions, future study in this area will be required, 
with particular attention paid to obtaining a more comprehensive and objective 
assessment of HIV status. It is worth noting that our sample was recruited almost 
exclusively from medical settings and HIV treatment centers, and active engagement with 
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a course of HAART treatment was an inclusion criterion for study participation. 
Together, these factors provide some support for the notion that the neurovirulant aspects 
of HIV were controlled to a greater degree than if recruitment took place from a non-
treatment-seeking population. However, because medication adherence decreases with 
increasing amounts of alcohol use, this may not have been the case for heavy drinkers.  
No firm conclusions can be made from this study regarding additive or synergistic 
effects of alcohol + HIV, and these cross-sectional findings do not elucidate specific 
HIV-related changes in cognition. Existing literature suggests that relations among CD4 
count, viral load, and cognitive performance are complex. They are perhaps best 
understood when monitored over time, as lifetime variability in these values may be more 
clinically informative than direct associations at a given time point. For example, a 
person’s lowest lifetime CD4 value is associated with risk for cognitive impairment (Ellis 
et al., 2011), and Marcotte et al. (2003) found that HIV+ individuals with high viral loads 
and low CD4 counts in the year after seroconversion were six times more likely to be 
diagnosed with HAND. Future neuropsychological studies should assess these factors 
longitudinally.  
A separate limitation of this study pertains to test selection. Due to time and 
constraints in research staff training, no traditional paper-and-pencil neuropsychological 
measures were included to corroborate CogState performance. It is therefore possible that 
the domains purported to be measured by the computerized tasks actually differed from 
their more commonly used verbal or paper-and-pencil equivalents. We also did not 
include a measure of prospective memory, which would have been clinically informative. 
Woods et al. (2008) and others have provided evidence that prospective memory 
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impairment impacts activities of daily living by preventing individuals from properly 
noticing or reacting to prospective memory cues.  
In terms of selecting the self-report measure, use of the PAOFI assessment tool 
was advocated by Dr. Robert Heaton and the HIV Neurobehavioral Research Group at 
the University of California – San Diego. However, the focus of the current study on 
prefrontal processes may have warranted additional data collection that was specific to 
self-reported attentional or dysexecutive problems. The Frontal Systems Behavior Scale 
(FrSBe; Grace & Malloy, PAR Inc.), which includes self-report subscales on apathy, 
disinhibition, and executive functioning, was a strong candidate in this realm. The FrSBe 
has been well-validated in the context of dementia, traumatic brain injury, and multiple 
sclerosis (e.g., Stout et al., 2003), but it was ultimately not selected for inclusion in this 
study due to the time required for administration and scoring (25 minutes), and a lack of 
existing literature showing the sensitivity of the FrSBe within non-dementia HIV 
populations.  
 
4.5 Summary and Conclusions 
Despite these limitations, the present results highlight the fact that demographic 
variables must be considered when evaluating the neurocognitive performance of HIV+ 
individuals (e.g., years of education and verbal IQ). There was a surprising lack of 
association between level of alcohol use and cognitive functioning in most domains 
examined in this study, but after comparing a subset of the lightest drinkers and heaviest 
drinkers in our sample, verbal learning performance emerged as significantly different 
between groups. This finding suggests that, as previously reported by Fama and 
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colleagues, HIV+ heavy drinkers may exhibit a more impaired cognitive profile than 
HIV+ light drinkers. Further neuropsychological research is needed on the complex 
interplay among HIV disease course, alcohol consumption level, and premorbid 
intellectual functioning. Future study designs should ideally be longitudinal and tailored 
to allow consideration of how each factor contributes uniquely to variance in cognitive 
performance.  
Second, our findings further support a discrepancy between self-appraisal of 
cognitive abilities in HIV and objective performance measures of cognitive functioning. 
Both depressive symptoms and level of alcohol use accounted for variance in self-
reported cognitive concerns on the PAOFI, whereas actual task performance did not. 
From a clinical perspective, these findings represent a call to action. Clinicians must 
carefully consider their assessment methods when making judgments about HAND 
diagnosis and impaired everyday functioning. Although similarly small correlations 
between subjective ratings and objective neuropsychological performance have been 
reported for other memory disorders, the diagnostic implications are especially important 
for HIV and assessing the level of HAND. As Thames et al. (2011; p. 224) described, 
“…over-reliance on self-reported functional status poses risk for error … [because 
HAND] diagnoses require documentation of both cognitive impairment and associated 
functional disability in everyday life.”  It is clear that substantial work will be required to 
determine the most effective methods for assessing everyday cognitive functioning in 
HIV, particularly among individuals with co-occurring heavy drinking and/or depressive 
symptoms. 
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Third, we tested the CogState battery. We found that most domains tested (except 
attention and working memory) showed significant associations with a well-validated 
measure of intellectual functioning (WTAR Verbal IQ). The GMLT task of executive 
functioning correlated with decision-making on the IGT. Advantages of using CogState 
included its brief administration time, limited staff training/administration demands, and 
automated scoring and data collection with greater precision of measurement. The 
CogState battery is likely to be useful in future research on HIV and HAND, particularly 
in studies that adequately address the design limitations outlined above. 
From a theoretical and clinical perspective, the neurocognitive consequences of 
HIV infection are worthy of future study. Research that considers data from 
neuroimaging, self-report measures of substance use and psychiatric symptoms, and 
comprehensive neuropsychological testing will be particularly enlightening. Access to 
HAART has yielded some success in improving neurocognitive outcomes in HIV, yet 
from a psychological perspective, more specific behavioral interventions for individuals 
with HAND are needed.  A better understanding of the negative influence of treatable 
psychological factors on cognition in HIV, especially heavy drinking and depression, 
may help to inform such interventions.  
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Table 1. Subtypes of HIV-Associated Neurocognitive Impairment (HAND)  
Diagnosis Criteria 
Asymptomatic Neurocognitive 
Impairment  
(ANI) 
- Cognitive decline in 2 domains that is greater than 1 
Standard Deviation (SD) below the normative level 
-No reported interference with everyday functioning 
 
HIV-Associated Mild 
Neurocognitive Disorder  
(MND) 
- Cognitive decline in 2 domains that is greater than 1 SD 
below the normative level 
-Mild interference with everyday functioning 
 
HIV-Associated Dementia  
(HAD) or AIDS Dementia 
Complex (ADC) 
- Cognitive decline in 2 domains that is greater than 2 SD 
below the normative level 
-Marked interference with everyday functioning 
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Table 2. Individuals Excluded from Study Participation 
 
Phone Screen 
Reason for Exclusion 
Number of 
Individuals 
Study Visit 
Reason for Exclusion 
Number of 
Individuals 
Exclusionary Medication 82 (32%) Drug Dependence 16 (29%) 
Drug Dependence 54 (21%) WTAR Verbal IQ < 80 15 (27%) 
Psychiatric Diagnosis 35 (14%) Psychiatric Diagnosis 9 (16%) 
Did not meet  
HIV inclusion criterion 
30 (12%) Mini Mental Score < 25 7 (13%) 
Did not meet  
Alcohol inclusion 
criterion 
28 (11%) Exclusionary 
Medication 
 
4 (7%) 
Comorbid neurological 
condition 
17 (7%) Positive BrAC 3 (5%) 
Unable to attend visit 7 (3%) Other 1 (2%) 
Age 1 (<1%) TOTAL EXCLUDED 55 
Self-professed illiteracy 1 (<1%) 
Other 4 (2%) 
TOTAL EXCLUDED 259 
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Table 3. Descriptive Characteristics of Study Sample (n = 122) 
 
Sample Characteristic Mean (SD) or Percent 
Sex 
Male 
 
84% 
Age 47 (10.1) 
Race/Ethnicity 
European-American 
African-American 
Hispanic 
Filipino 
 
24% 
72% 
3% 
<1% 
Years of Education 14 (2.6) 
WTAR Verbal IQ 97 (13.0) 
PHQ-9 Depression Score (0 - 27) 4.6 (5.0) 
PAOFI Summary Score (19 - 114) 93.2 (14.9) 
Impulsivity Score (11 - 44) 32 (8.4) 
Alcohol Use in Past 3 Months 
Number of Drinking Days 
Number of Drinks per Drinking Day 
Number of Heavy Drinking Days 
 
36 (27.8) 
5 (4.4) 
16 (24.3) 
HAART Adherence in Past Month 
Number of Days with 100% Adherence 
Overall % Adherence 
 
28 (3.2) 
94% (10.1) 
Cannabis Use in Past Month 
Number of Days Used 
Amount Used (# of joints) 
 
3 (7.4) 
6 (19.6) 
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Table 4. Inter-correlations among neurocognitive tasks. Significant correlations (p < .05) 
are bolded. Lower scores in the domains of psychomotor speed, attention, executive 
function, and impulsive decision making are indicative of stronger performance.  
DET = Detection Task, ID = Identification Task, ONB = One-Back Task, CL = Card Learning Task, SL = 
Shopping List Task, SL-R = Shopping List Recall Trial, GMLT = Groton Maze Learning Task, IGT = Iowa 
Gambling Task.  
 
TASK Psychomotor 
Speed 
(DET) 
Attention 
(ID) 
Working 
Memory 
(ONB) 
Visual 
Memory 
(CL) 
Verbal 
Memory 
Immediate 
(SL) 
Verbal 
Memory 
Delayed 
(SL-R) 
Executive 
Function 
(GMLT) 
Impulsive 
Decision 
Making 
(IGT) 
Psychomotor 
Speed 
(DET) 
-        
Attention 
(ID) 
.57 -       
Working 
Memory 
(ONB) 
-.08 -.01 -      
Visual 
Memory 
(CL) 
-.24 -.11 .51 -     
Verbal 
Memory – 
Initial 
(SL) 
-.17 -.14 .16 .33 -    
Verbal 
Memory – 
Delayed 
(SL-R) 
-.11 -.03 .12 .27 .71 -   
Executive 
Function 
(GMLT) 
.30 .20 -.29 -.39 -.28 .14 -  
Impulsive 
Decision-
Making 
(IGT) 
-.16 -.27 .01 .05 .13 .06 -.21 - 
Verbal IQ 
(WTAR) 
-.21 -.12 .10 .17 .42 .25 -.34 .33 
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Table 5. Differences between Light Drinking (LD) and Heavy Drinking (HD) Groups 
 
Variable Light Drinkers (n = 28) 
M (SD) 
Heavy Drinkers (n = 31) 
M (SD) 
p-value 
Years of Education 15.3 (2.7) 12.7 (2.2) 0.0002 
WTAR Verbal IQ 104.5 (14.8) 93.8 (10.2) 0.002 
PHQ-9 Depression 
Score 
(0-27) 
2.1 (2.5) 6.3 (5.8) 0.001 
PAOFI Summary 
Score  
(19 – 114) 
101.2 (11.1) 87.4 (15.6) 0.0003 
Impulsivity Score 
(11 – 44) 
38.4 (5.9) 27.5 (7.1) <0.0001 
HAART Medication 
Adherence (%) 
97.6% (4.0) 88.5% (17.4) 0.04 
Cannabis Use 
(Days in Past Month) 
1.9 (5.1) 6.8 (11.2) 0.009 
Words Recalled on 
Shopping List Verbal 
Memory Task 
(0-30) 
25.6 (3.7) 23.4 (4.3) 0.04 
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Table 6. Correlation matrix for self-appraisal of cognitive complaints in memory, 
executive function, and impulsivity in relation to corresponding neuropsychological 
performance. Statistically significant correlations (p < 0.05) are bolded. 
 
Assessment PAOFI 
Memory 
Scale 
PAOFI 
Executive 
Function  
Scale 
Impulsivity  
Scale 
Verbal 
Memory 
Immediate 
(SL) 
Verbal 
Memory 
Delayed 
(SL-R) 
Executive 
Function 
(GMLT) 
PAOFI 
Memory 
Scale 
-      
PAOFI 
Executive 
Function 
Scale 
.76 -     
Impulsivity 
Scale 
.63 .61 -    
Verbal 
Memory 
Immediate 
(SL) 
.02 .13 .14 -   
Verbal 
Memory 
Delayed 
(SL-R) 
-.02 .07 .09 .71 -  
Executive 
Function 
(GMLT) 
-.08 -.06 -.17 -.28 -.14 - 
Impulsive 
Decision 
Making 
(IGT) 
.16 -.11 .16 .13 .06 -.21 
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Figure 1. Mean z-scores for CogState tasks by domain. All z-scores were calculated 
using normative data collected from age-matched healthy controls who previously 
completed CogState testing. Error bars represent 95% confidence intervals. 
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